To assess the role of B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), two critical B cell-modulating cytokines, as potential biomarkers of disease activity and treatment biomarkers in OMS. The gene discussed is TNFSF13B; the disease is opsoclonus-myoclonus syndrome.